Tobraza Ointment is a topical formulation containing Tofacitinib Citrate 2% w/w, commonly recommended under medical supervision for managing certain inflammatory skin conditions. As a Janus Kinase (JAK) inhibitor, it works by modulating pathways involved in skin inflammation, helping reduce redness, itching, and irritation when applied to affected areas.
Designed for localized use, Tobraza Ointment is suitable for targeted application and is typically included as part of a doctor-directed treatment plan for chronic inflammatory skin concerns.
